TROUGH LEVELS TO INFLIXIMAB  AT W6 ARE PREDICTIVE OF REMISSION AT W14, IN PEDIATRIC CROHN DISEASE.

Christine Martinez-Vinson  1     Olivier Courbette  1     Camille Aupiais  1     Jérome Viala  1     Jean-Pierre Hugot  1    
1 Hôpital Robert Debré,Gastroentérologie pédiatrique,Paris,France

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing